Skip to main content
Clinical Trials/IRCT20200825048515N41
IRCT20200825048515N41
Recruiting
Phase 2

Evaluation of the effect of extracorporeal shockwave therapy after botulinum toxin injection on cuff muscle spasticity improvement in patients with multiple sclerosis

Esfahan University of Medical Sciences0 sites20 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Multiple sclerosis.
Sponsor
Esfahan University of Medical Sciences
Enrollment
20
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Definitive diagnosis of multiple sclerosis based on the opinion of a neurologist
  • Presence of spasticity in the cuff muscles (based on a score of more than 1 on the modified Ashworth scale (MAS)
  • consent to participate in the study

Exclusion Criteria

  • Having cognitive disorders (in advanced stages of the disease)
  • Having myopathy or peripheral nerve disease
  • Having a pace maker
  • Pre\-injection of botulinum toxin during the last 6 months
  • Having cuff muscle atrophy
  • Having coagulation disorders
  • History of previous surgery or fracture at the site of spastic muscles

Outcomes

Primary Outcomes

Not specified

Similar Trials